Results 1 to 10 of about 1,408,984 (372)

Prevalence and predictors of suicidality among adults initiating office-based buprenorphine [PDF]

Addiction Science & Clinical Practice, 2023
Background Individuals who have substance use disorders may have an elevated risk of suicidality. This study sought to examine the prevalence of, and identify factors associated with, suicidality in adults with opioid use disorder (OUD) initiating office-
Michelle R. Lent, Karen L. Dugosh, Emily Hurstak, Hannah R. Callahan, Kimberly Mazur, The Greater Philadelphia Opioid Use Disorder Research Group   +5 more
doaj   +3 more sources

Comorbid opioid use is undertreated among forensic patients with schizophrenia [PDF]

Substance Abuse Treatment, Prevention, and Policy, 2018
Background Substance use disorders are associated with poorer clinical outcomes in patients with schizophrenia. There is no specific treatment for amphetamine or cannabis use disorder, but methadone and buprenorphine are used as replacement therapy in ...
Kristiina Kivimies, Eila Repo-Tiihonen, Hannu Kautiainen, Jari Tiihonen   +3 more
doaj   +4 more sources

Association between recent overdose and chronic pain among individuals in treatment for opioid use disorder. [PDF]

PLoS ONE, 2022
Chronic pain increases risk for opioid overdose among individuals with opioid use disorder. The purpose of this study is to evaluate the relationship between recent overdose and whether or not chronic pain is active.
Sarah M Hartz, Robert C Culverhouse, Carrie M Mintz, Matthew S Ellis, Zachary A Kasper, Patricia Cavazos-Rehg, Richard A Grucza, Laura J Bierut, Theodore J Cicero   +8 more
doaj   +4 more sources

Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descent [PDF]

BMC Psychiatry, 2020
Background Genome Wide Association Studies (GWAS) have been conducted to identify genes and pathways involved in development of opioid use disorder. This study extends the first GWAS of substance use disorder (SUD) patients from the United Arab Emirates (
Hiba Alblooshi, Habiba Al Safar, Ahmed El Kashef, Hamad Al Ghaferi, Mansour Shawky, Gary K. Hulse, Guan K. Tay   +6 more
doaj   +3 more sources

A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome [PDF]

BMC Pediatrics, 2019
Background Adult opioid use and neonatal abstinence syndrome (NAS) are growing public health problems in the United States (U.S.). Our objective was to determine how opioid use disorder treatment access impacts the relationship between adult opioid use ...
Elizabeth R. Wolf, Sebastian T. Tong, Roy T. Sabo, Steven H. Woolf, Kassie Abbinanti, James Pecsok, Alex H. Krist   +6 more
doaj   +3 more sources

Opioid Use Disorder [PDF]

North Carolina Medical Journal, 2018
The current opioid epidemic is devastating to the lives of individuals, families, and communities, but there are effective treatment approaches available. Treatment that combines proven medications with behavioral therapies and other supports is giving many in North Carolina the opportunity to engage in successful recovery.
Smith Worth, Kenny House
openalex   +4 more sources

A Comparison of Veterans with Problematic Opioid Use Identified through Natural Language Processing of Clinical Notes versus Using Diagnostic Codes [PDF]

arXiv
Background: Electronic health records (EHRs) are a data source for opioid research. Opioid use disorder is known to be under-coded as a diagnosis, yet problematic opioid use can be documented in clinical notes. Objectives: Our goals were 1) to identify problematic opioid use from a full range of clinical notes; and 2) to compare the characteristics ...
Kupersmith, Joel, Ma, Phillip, Sandbrink, Friedhelm, Spevak, Christopher, Workman, Terri Elizabeth, Zeng-Treitler, Yan Cheng Qing   +5 more
arxiv   +2 more sources

Opioid use disorder [PDF]

Nature Reviews Disease Primers, 2020
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse.
George F. Koob, Nora D. Volkow, Mark W. Tyndall, Louisa Degenhardt, Matthew Hickman, Kimberly Johnson, Sharon L. Walsh, John Strang, John Strang, Brandon D.L. Marshall   +9 more
  +9 more sources

Opioid use disorder in pregnancy [PDF]

Mental Health Clinician, 2019
AbstractThe number of pregnant people affected by the opioid epidemic in the United States continues to rise. The following key aspects of opioid use disorder in pregnancy are explored through the progression of a pregnancy via a patient case: treatment options, treatment decisions, substance use screening, dosing modifications, and other aspects of ...
Mary Malebranche, Anshula Ambasta
  +10 more sources

Comorbid Opioid Use Disorder in Body Dysmorphic Disorder

European Psychiatry, 2022
Introduction Body Dysmorphic Disorder (BDD) is a severe and common disorder that consists of distressing or impairing preoccupation with nonexistent or slight flaws in one’s physical appearance.
J. Kim, O. Alli-Balogun, G. Gill, P. Korenis, S. Mitra   +4 more
doaj   +1 more source